SANES

8.883

+0.42%↑

BBVA

18.02

+0.7%↑

MUV2

535.6

+1.21%↑

INGA

21.835

+1.16%↑

KBC

105.05

+0.24%↑

SANES

8.883

+0.42%↑

BBVA

18.02

+0.7%↑

MUV2

535.6

+1.21%↑

INGA

21.835

+1.16%↑

KBC

105.05

+0.24%↑

SANES

8.883

+0.42%↑

BBVA

18.02

+0.7%↑

MUV2

535.6

+1.21%↑

INGA

21.835

+1.16%↑

KBC

105.05

+0.24%↑

SANES

8.883

+0.42%↑

BBVA

18.02

+0.7%↑

MUV2

535.6

+1.21%↑

INGA

21.835

+1.16%↑

KBC

105.05

+0.24%↑

SANES

8.883

+0.42%↑

BBVA

18.02

+0.7%↑

MUV2

535.6

+1.21%↑

INGA

21.835

+1.16%↑

KBC

105.05

+0.24%↑

Search

Gimv NV

Slēgts

SektorsFinanšu

46.8 1.85

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

45.95

Max

46.95

Galvenie mērījumi

By Trading Economics

Pārdošana

114M

P/E

Sektora vidējais

5.944

28.864

EPS

2.43

Dividenžu ienesīgums

5.77

Darbinieki

94

EBITDA

76M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

5.77%

3.92%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.6B

Iepriekšējā atvēršanas cena

44.95

Iepriekšējā slēgšanas cena

46.8

Ziņu noskaņojums

By Acuity

50%

50%

204 / 528 Rangs Finance

Gimv NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 24. nov. 21:54 UTC

Iegādes, apvienošanās, pārņemšana

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

2025. g. 24. nov. 18:26 UTC

Galvenie tirgus virzītāji

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

2025. g. 24. nov. 23:49 UTC

Tirgus saruna

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

2025. g. 24. nov. 23:08 UTC

Tirgus saruna

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

2025. g. 24. nov. 23:08 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 24. nov. 22:56 UTC

Tirgus saruna
Peļņas

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

2025. g. 24. nov. 22:47 UTC

Tirgus saruna

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

2025. g. 24. nov. 22:36 UTC

Tirgus saruna
Peļņas

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

2025. g. 24. nov. 22:32 UTC

Peļņas

Webco Industries 1Q EPS $6.79 >WEBC

2025. g. 24. nov. 22:07 UTC

Peļņas

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

2025. g. 24. nov. 22:07 UTC

Peļņas

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

2025. g. 24. nov. 22:06 UTC

Peļņas

Couche-Tard 2Q Adj EPS 78c >ATD.T

2025. g. 24. nov. 22:06 UTC

Peļņas

Couche-Tard 2Q Rev $17.9B >ATD.T

2025. g. 24. nov. 22:06 UTC

Peļņas

Couche-Tard 2Q EPS 79c >ATD.T

2025. g. 24. nov. 22:05 UTC

Peļņas

Couche-Tard 2Q Rev $17.9B >ATD.T

2025. g. 24. nov. 22:05 UTC

Peļņas

Couche-Tard 2Q Net $740.6M >ATD.T

2025. g. 24. nov. 22:05 UTC

Peļņas

Couche-Tard 2Q Adj EPS 78c >ATD.T

2025. g. 24. nov. 22:05 UTC

Peļņas

Couche-Tard 2Q EPS 79c >ATD.T

2025. g. 24. nov. 21:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2025. g. 24. nov. 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 24. nov. 21:44 UTC

Tirgus saruna

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

2025. g. 24. nov. 21:39 UTC

Iegādes, apvienošanās, pārņemšana

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

2025. g. 24. nov. 20:42 UTC

Tirgus saruna

Oil Futures Snap Three-Session Losing Streak -- Market Talk

2025. g. 24. nov. 20:41 UTC

Tirgus saruna

U.S. Natural Gas Futures Settle Lower -- Market Talk

2025. g. 24. nov. 19:56 UTC

Iegādes, apvienošanās, pārņemšana

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

2025. g. 24. nov. 18:26 UTC

Tirgus saruna

Crude Futures Move Higher in Choppy Trade -- Market Talk

2025. g. 24. nov. 17:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2025. g. 24. nov. 17:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 24. nov. 17:09 UTC

Tirgus saruna

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

2025. g. 24. nov. 16:52 UTC

Iegādes, apvienošanās, pārņemšana

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Gimv NV Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

204 / 528 Rangs Finanšu

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat